Search results
How a racially biased kidney test harmed Black patients
KPBS San Diego· 1 day agoOn today's midday edition , racial bias in a kidney test prevented thousands of black patients from getting the transplants they needed. For years , a racially biased lab test prevented thousands ...
May 31 2024 This Week in Cardiology
Medscape· 5 days agoFor more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple...
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
Clinical Trials Arena via Yahoo Finance· 6 days agoThe interim results showed that a nine-dose regimen of felzartamab demonstrated a deep and durable...
Council Post: Why Scalable Approaches Are Needed For Earlier Intervention Of Chronic Kidney Disease
Forbes· 5 days agoSalvatore Viscomi MD, CEO and cofounder of Carna Health, is an entrepreneur with a passion for...
Keep your kidneys healthy - BusinessWorld Online
BusinessWorld· 2 days agoThe number of Filipinos with chronic kidney disease (CKD) requiring dialysis is on the rise, warns the Philippine Society of Nephrology (PSN). A...
This Simple Change Could Help Diagnose Millions More Cases of Lung Disease
Scientific American· 5 days agoFor decades, clinical algorithms that were used to diagnose disease have included race as a...
Opinion | Former Surgeon General's Exorbitant ED Bill: Impact of 'Cover Your Ass' Care
MedPage Today· 6 days agoIn this exclusive video interview, Jeremy Faust, MD, editor-in-chief of MedPage Today, and Jerome...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with FDA, all patients randomized from start of TEBE-AM
Effect of a diabetes-specific formula in non-diabetic inpatients with stroke: a randomized...
Nature· 6 days agoA randomised controlled clinical trial was developed in patients without diabetes mellitus admitted due to stroke and with an indication for nutritional support by nasogastric tube. The primary ...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 3 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related